Goldman Sachs’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
1,691,286
+121,368
| +8% | +$789K | ﹤0.01% | 2205 |
|
|
2025
Q1 | $12.4M | Buy |
1,569,918
+1,097,679
| +232% | +$8.7M | ﹤0.01% | 2060 |
|
|
2024
Q4 | $5.98M | Sell |
472,239
-1,302,068
| -73% | -$16.5M | ﹤0.01% | 2718 |
|
|
2024
Q3 | $24.7M | Sell |
1,774,307
-128,801
| -7% | -$1.79M | ﹤0.01% | 1574 |
|
|
2024
Q2 | $26.2M | Sell |
1,903,108
-234,383
| -11% | -$3.23M | ﹤0.01% | 1404 |
|
|
2024
Q1 | $35.3M | Buy |
2,137,491
+18,642
| +0.9% | +$308K | 0.01% | 1181 |
|
|
2023
Q4 | $30.9M | Buy |
2,118,849
+472,654
| +29% | +$6.9M | 0.01% | 1258 |
|
|
2023
Q3 | $20.2M | Sell |
1,646,195
-746,328
| -31% | -$9.16M | ﹤0.01% | 1491 |
|
|
2023
Q2 | $28.6M | Buy |
2,392,523
+109,187
| +5% | +$1.3M | 0.01% | 1303 |
|
|
2023
Q1 | $30.5M | Buy |
2,283,336
+515,234
| +29% | +$6.89M | 0.01% | 1219 |
|
|
2022
Q4 | $38M | Buy |
1,768,102
+42,960
| +2% | +$924K | 0.01% | 1150 |
|
|
2022
Q3 | $34.6M | Sell |
1,725,142
-169,395
| -9% | -$3.39M | 0.01% | 1192 |
|
|
2022
Q2 | $33.9M | Buy |
1,894,537
+1,863,325
| +5,970% | +$33.4M | 0.01% | 1224 |
|
|
2022
Q1 | $310K | Buy |
31,212
+6,666
| +27% | +$66.2K | ﹤0.01% | 4868 |
|
|
2021
Q4 | $414K | Buy |
+24,546
| New | +$414K | ﹤0.01% | 4616 |
|
|
2021
Q3 | – | Sell |
-11,594
| Closed | -$264K | – | 5378 |
|
|
2021
Q2 | $264K | Buy |
+11,594
| New | +$264K | ﹤0.01% | 4776 |
|